Review of Hypofractionated Small Volume Radiotherapy for Early-stage Non-small Cell Lung Cancer

Clinical Oncology

Volumn 20, Issue 9, 2008, Pages 666-676

  Brock, J ^a   Ashley, S ^a   Bedford, J ^a   Nioutsikou, E ^a   Partridge, M ^a   Brada, M ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Hypofractionation; non small cell lung cancer; radiotherapy; stereotactic

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; BREATHING MECHANICS; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE SURVIVAL; DOSIMETRY; EXTERNAL BEAM RADIOTHERAPY; HUMAN; HYPOFRACTIONATED SMALL VOLUME RADIOTHERAPY; IMMOBILIZATION; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; MEDLINE; ONCOLOGICAL PARAMETERS; PATIENT POSITIONING; PATIENT SAFETY; PHOTON THERAPY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION EXPOSURE; RADIATION HAZARD; RADIATION INJURY; STEREOTACTIC TREATMENT; SURVIVAL RATE; SURVIVAL TIME; THREE DIMENSIONAL IMAGING; TREATMENT OUTCOME;

CARCINOMA, NON-SMALL-CELL LUNG; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; LUNG NEOPLASMS; RADIOSURGERY; SURVIVAL ANALYSIS;

EID: 52749094954     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2008.06.005     Document Type: Article

References (77)

1. Qiao X., Tullgren O., Lax I., Sirzen F., and Lewensohn R. The role of radiotherapy in treatment of stage I non-small cell lung cancer. Lung Cancer 41 1 (2003) 1-11
2. Narayan S., Henning G.T., Ten Haken R.K., Sullivan M.A., Martel M.K., and Hayman J.A. Results following treatment to doses of 92.4 or 102.9 Gy on a phase I dose escalation study for non-small cell lung cancer. Lung Cancer 44 1 (2004) 79-88
3. Belderbos J.S., Heemsbergen W.D., De Jaeger K., Baas P., and Lebesque J.V. Final results of a phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 66 1 (2006) 126-134
4. Kong F.M., Hayman J.A., Griffith K.A., et al. Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis. Int J Radiat Oncol Biol Phys 65 4 (2006) 1075-1086
5. Hayman J.A., Martel M.K., Ten Haken R.K., et al. Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial. J Clin Oncol 19 1 (2001) 127-136
6. Bradley J., Graham M.V., Winter K., et al. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys 61 2 (2005) 318-328
7. Belani C.P., Choy H., Bonomi P., et al. Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: a randomized phase II locally advanced multi-modality protocol. J Clin Oncol 23 25 (2005) 5883-5891
8. Fournel P., Robinet G., Thomas P., et al. Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Francais de Pneumo-Cancerologie NPC 95-01 study. J Clin Oncol 23 25 (2005) 5910-5917
9. Furuse K., Fukuoka M., Kawahara M., et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 17 9 (1999) 2692-2699
10. Zatloukal P., Petruzelka L., Zemanova M., et al. Concurrent versus sequential chemoradiotherapy with cisplatin and vinorelbine in locally advanced non-small cell lung cancer: a randomized study. Lung Cancer 46 1 (2004) 87-98
11. Saunders M., Dische S., Barrett A., Harvey A., Gibson D., and Parmar M. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomised multicentre trial. CHART Steering Committee. Lancet 350 9072 (1997) 161-165
12. Nagata Y., Negoro Y., Aoki T., et al. Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame. Int J Radiat Oncol Biol Phys 52 4 (2002) 1041-1046
13. Wulf J., Hadinger U., Oppitz U., Thiele W., Ness-Dourdoumas R., and Flentje M. Stereotactic radiotherapy of targets in the lung and liver. Strahlenther Onkol 177 12 (2001) 645-655
14. Kim D.J., Murray B.R., Halperin R., and Roa W.H. Held-breath self-gating technique for radiotherapy of non-small-cell lung cancer: a feasibility study. Int J Radiat Oncol Biol Phys 49 1 (2001) 43-49
15. Onishi H., Kuriyama K., Komiyama T., et al. CT evaluation of patient deep inspiration self-breath-holding: how precisely can patients reproduce the tumor position in the absence of respiratory monitoring devices?. Med Phys 30 6 (2003) 1183-1187
16. Wong J.W., Sharpe M.B., Jaffray D.A., et al. The use of active breathing control (ABC) to reduce margin for breathing motion. Int J Radiat Oncol Biol Phys 44 4 (1999) 911-919
17. Ford E.C., Mageras G.S., Yorke E., Rosenzweig K.E., Wagman R., and Ling C.C. Evaluation of respiratory movement during gated radiotherapy using film and electronic portal imaging. Int J Radiat Oncol Biol Phys 52 2 (2002) 522-531
18. Giraud P., Yorke E., Ford E.C., et al. Reduction of organ motion in lung tumors with respiratory gating. Lung Cancer 51 1 (2006) 41-51
19. Brown W.T., Wu X., Wen B.C., et al. Early results of CyberKnife image-guided robotic stereotactic radiosurgery for treatment of lung tumors. Comput Aided Surg 12 5 (2007) 253-261
20. Wolthaus J.W., Schneider C., Sonke J.J., et al. Mid-ventilation CT scan construction from four-dimensional respiration-correlated CT scans for radiotherapy planning of lung cancer patients. Int J Radiat Oncol Biol Phys 65 5 (2006) 1560-1571
21. Guckenberger M., Meyer J., Vordermark D., Baier K., Wilbert J., and Flentje M. Magnitude and clinical relevance of translational and rotational patient setup errors: a cone-beam CT study. Int J Radiat Oncol Biol Phys 65 3 (2006) 934-942
22. Oelfke U., Tucking T., Nill S., et al. Linac-integrated kV-cone beam CT: technical features and first applications. Med Dosim 31 1 (2006) 62-70
23. Purdie T.G., Moseley D.J., Bissonnette J.P., et al. Respiration correlated cone-beam computed tomography and 4DCT for evaluating target motion in stereotactic lung radiation therapy. Acta Oncol 45 7 (2006) 915-922
24. Sidhu K., Ford E.C., Spirou S., et al. Optimization of conformal thoracic radiotherapy using cone-beam CT imaging for treatment verification. Int J Radiat Oncol Biol Phys 55 3 (2003) 757-767
25. Onishi H., Kuriyama K., Komiyama T., et al. A new irradiation system for lung cancer combining linear accelerator, computed tomography, patient self-breath-holding, and patient-directed beam-control without respiratory monitoring devices. Int J Radiat Oncol Biol Phys 56 1 (2003) 14-20
26. Uematsu M., Shioda A., Suda A., et al. Intrafractional tumor position stability during computed tomography (CT)-guided frameless stereotactic radiation therapy for lung or liver cancers with a fusion of CT and linear accelerator (FOCAL) unit. Int J Radiat Oncol Biol Phys 48 2 (2000) 443-448
27. Shirato H., Shimizu S., Kunieda T., et al. Physical aspects of a real-time tumor-tracking system for gated radiotherapy. Int J Radiat Oncol Biol Phys 48 4 (2000) 1187-1195
28. Timmerman R., Galvin J., Michalski J., et al. Accreditation and quality assurance for Radiation Therapy Oncology Group: multicenter clinical trials using stereotactic body radiation therapy in lung cancer. Acta Oncol 45 7 (2006) 779-786
29. Faria S.L., Bezjak A., Purdie T.G., et al. Absence of toxicity with hypofractionated 3-dimensional radiation therapy for inoperable, early stage non-small cell lung cancer. Radiat Oncol 1 (2006) 42
30. Franks K.N., Bezjak A., Purdie T.G., et al. Early results of image-guided radiation therapy in lung stereotactic body radiotherapy (SBRT). Clin Oncol (R Coll Radiol) 19 3 (2007) S10
31. Fukumoto S., Shirato H., Shimzu S., et al. Small-volume image-guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable stage I nonsmall cell lung carcinomas. Cancer 95 7 (2002) 1546-1553
32. Hoyer M. Prospective study on stereotactic radiotherapy of limited stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 63 2S (2005) S396
33. Lee S.W., Choi E.K., Park H.J., et al. Stereotactic body frame based fractionated radiosurgery on consecutive days for primary or metastatic tumors in the lung. Lung Cancer 40 3 (2003) 309-315
34. Nagata Y., Takayama K., Matsuo Y., et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 63 5 (2005) 1427-1431
35. Onimaru R., Shirato H., Shimizu S., et al. Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers. Int J Radiat Oncol Biol Phys 56 1 (2003) 126-135
36. Onishi H., Araki T., Shirato H., et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 101 7 (2004) 1623-1631
37. Timmerman R., Papiez L., McGarry R., et al. Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 124 5 (2003) 1946-1955
38. Wulf J., Haedinger U., Oppitz U., Thiele W., Mueller G., and Flentje M. Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: a noninvasive treatment approach in medically inoperable patients. Int J Radiat Oncol Biol Phys 60 1 (2004) 186-196
39. Xia T., Li H., Sun Q., et al. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable stage I/II non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 66 1 (2006) 117-125
40. Zimmermann F.B., Geinitz H., Schill S., et al. Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC). Acta Oncol 45 7 (2006) 796-801
41. Baumann P., Nyman J., Lax I., et al. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries. Acta Oncol 45 7 (2006) 787-795
42. Beitler J.J., Badine E.A., El-Sayah D., et al. Stereotactic body radiation therapy for nonmetastatic lung cancer: an analysis of 75 patients treated over 5 years. Int J Radiat Oncol Biol Phys 65 1 (2006) 100-106
43. Uematsu M., Shioda A., Suda A., et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience. Int J Radiat Oncol Biol Phys 51 3 (2001) 666-670
44. Fang L.C., Komaki R., Allen P., Guerrero T., Mohan R., and Cox J.D. Comparison of outcomes for patients with medically inoperable stage I non-small-cell lung cancer treated with two-dimensional vs. three-dimensional radiotherapy. Int J Radiat Oncol Biol Phys 66 1 (2006) 108-116
45. Martel M.K., Strawderman M., Hazuka M.B., Turrisi A.T., Fraass B.A., and Lichter A.S. Volume and dose parameters for survival of non-small cell lung cancer patients. Radiother Oncol 44 1 (1997) 23-29
46. Gauden S., Ramsay J., and Tripcony L. The curative treatment by radiotherapy alone of stage I non-small cell carcinoma of the lung. Chest 108 5 (1995) 1278-1282
47. Uematsu M., Sonderegger M., Shioda A., et al. Daily positioning accuracy of frameless stereotactic radiation therapy with a fusion of computed tomography and linear accelerator (focal) unit: evaluation of z-axis with a z-marker. Radiother Oncol 50 3 (1999) 337-339
48. Uematsu M., Shioda A., Tahara K., et al. Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: a preliminary experience. Cancer 82 6 (1998) 1062-1070
49. Nyman J., Johansson K.A., and Hulten U. Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer-mature results for medically inoperable patients. Lung Cancer 51 1 (2006) 97-103
50. Underberg R.W., Lagerwaard F.J., Slotman B.J., Cuijpers J.P., and Senan S. Benefit of respiration-gated stereotactic radiotherapy for stage I lung cancer: an analysis of 4dct datasets. Int J Radiat Oncol Biol Phys 62 2 (2005) 554-560
51. Giraud P., Yorke E., Jiang S., Simon L., Rosenzweig K., and Mageras G. Reduction of organ motion effects in IMRT and conformal 3D radiation delivery by using gating and tracking techniques. Cancer Radiother 10 5 (2006) 269-282
52. Ruggieri R. Hypofractionation in non-small cell lung cancer (NSCLC): suggestions from modelling both acute and chronic hypoxia. Phys Med Biol 49 20 (2004) 4811-4823
53. Bortfeld T., and Schlegel W. Optimization of beam orientations in radiation therapy: some theoretical considerations. Phys Med Biol 38 2 (1993) 291-304
54. Das S., Cullip T., Tracton G., et al. Beam orientation selection for intensity-modulated radiation therapy based on target equivalent uniform dose maximization. Int J Radiat Oncol Biol Phys 55 1 (2003) 215-224
55. D'Souza W.D., Meyer R.R., and Shi L. Selection of beam orientations in intensity-modulated radiation therapy using single-beam indices and integer programming. Phys Med Biol 49 15 (2004) 3465-3481
56. Liu R., Buatti J.M., Howes T.L., Dill J., Modrick J.M., and Meeks S.L. Optimal number of beams for stereotactic body radiotherapy of lung and liver lesions. Int J Radiat Oncol Biol Phys 66 3 (2006) 906-912
57. Lax I., Blomgren H., Naslund I., and Svanstrom R. Stereotactic radiotherapy of malignancies in the abdomen. Methodological aspects. Acta Oncol 33 6 (1994) 677-683
58. de Pooter J.A., Mendez Romero A., Jansen W.P., et al. Computer optimization of noncoplanar beam setups improves stereotactic treatment of liver tumors. Int J Radiat Oncol Biol Phys 66 3 (2006) 913-922
59. Hall E.J., and Wuu C.S. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 56 1 (2003) 83-88
60. Kry S.F., Salehpour M., Followill D.S., et al. The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 62 4 (2005) 1195-1203
61. Guerrero M., and Li X.A. Extending the linear-quadratic model for large fraction doses pertinent to stereotactic radiotherapy. Phys Med Biol 49 20 (2004) 4825-4835
62. Macbeth F.R., Wheldon T.E., Girling D.J., et al. Radiation myelopathy: estimates of risk in 1048 patients in three randomized trials of palliative radiotherapy for non-small cell lung cancer. The Medical Research Council Lung Cancer Working Party. Clin Oncol (R Coll Radiol) 8 3 (1996) 176-181
63. Graham M.V., Purdy J.A., Emami B., et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 45 2 (1999) 323-329
64. Claude L., Perol D., Ginestet C., et al. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis. Radiother Oncol 71 2 (2004) 175-181
65. Clenton S.J., Fisher P.M., Conway J., Kirkbride P., and Hatton M.Q. The use of lung dose-volume histograms in predicting post-radiation pneumonitis after non-conventionally fractionated radiotherapy for thoracic carcinoma. Clin Oncol (R Coll Radiol) 17 8 (2005) 599-603
66. Chang M.Y., and Sugarbaker D.J. Surgery for early stage non-small cell lung cancer. Semin Surg Oncol 21 2 (2003) 74-84
67. Martini N., Bains M.S., Burt M.E., et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 109 1 (1995) 120-129
68. Naruke T., Goya T., Tsuchiya R., and Suemasu K. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 96 3 (1988) 440-447
69. Blomgren H. Radiosurgery for tumors in the body: clinical experience using a new method. J Radiosurgery 1 1 (1998) 63-74
70. Blomgren H., Lax I., Naslund I., and Svanstrom R. Stereotactic high dose fraction radiation therapy of extracranial tumors using an accelerator. Clinical experience of the first thirty-one patients. Acta Oncol 34 6 (1995) 861-870
71. Bradley J.D., Graham M.V., and Winter K. Acute and late toxicity results of RTOG 9311: A dose escalation study using conformal radiation therapy in patients with inoperable non-small cell lung cancer. Int J Radiat Oncol Biol Phys 57 2 Suppl (2003) S137-S138
72. Cardenes H., Timmerman R., and Papiez L. Extracranial stereotactic radioablation: Review of biological basis, technique and preliminary clinical experience. Oncologia 23 4 (2002) 193-199
73. Curran Jr. W.J., Moldofsky P.J., and Solin L.J. Analysis of the influence of elective nodal irradiation on postirradiation pulmonary function. Cancer 65 11 (1990) 2488-2493
74. Krol A.D., Aussems P., Noordijk E.M., Hermans J., and Leer J.W. Local irradiation alone for peripheral stage I lung cancer: Could we omit the elective regional nodal irradiation?. Int J Radiat Oncol Biol Phys 34 2 (1996) 297-302
75. Robertson J.M., Ten Haken R.K., Hazuka M.B., et al. Dose escalation for non-small cell lung cancer using conformal radiation therapy. Int J Radiat Oncol Biol Phys 37 5 (1997) 1079-1085
76. Slotman B.J., Antonisse I.E., and Njo K.H. Limited field irradiation in early stage (T1-2N0) non-small cell lung cancer. Radiother Oncol 41 1 (1996) 41-44
77. Williams T.E., Thomas Jr. C.R., and Turrisi III A.T. Counterpoint: better radiation treatment of non-small cell lung cancer using new techniques without elective nodal irradiation. Semin Radiat Oncol 10 4 (2000) 315-323